Suppr超能文献

在微型化条件下快速合成蛋白水解靶向嵌合体(Rapid-TAC)的平台。

A platform for the rapid synthesis of proteolysis targeting chimeras (Rapid-TAC) under miniaturized conditions.

机构信息

School of Pharmacy, University of Wisconsin-Madison, Madison, WI, 53705, USA.

Department of Chemistry, University of Wisconsin-Madison, Madison, WI, 53706, USA.

出版信息

Eur J Med Chem. 2022 Jun 5;236:114317. doi: 10.1016/j.ejmech.2022.114317. Epub 2022 Apr 1.

Abstract

Proteolysis targeting chimera (PROTAC) is one of the most frequently used technologies for targeted protein degradation. PROTACs are composed of target protein ligand, E3 ligase ligand and a linker between them. Traditional methods for the development of PROTACs involve step-by-step synthesis and are time consuming. Herein, we report a platform for the rapid synthesis of PROTACs (Rapid-TAC) via a traceless coupling reaction between ortho-phthalaldehyde (OPA) motif on the ligand of targeting protein and an amine fucntional group on the commercially available partial PROTAC library that is composed of different E3 ligase ligands and various types and lengths of linkers. Under our optimized miniaturized conditions, the full PROTACs can be synthesized in a high throughput manner and the products can be directly used for screening without any further manipulations including purification. We demonstrated the utility of this platform by quickly identifying active degraders for androgen receptor (AR) and BRD4 with DC of 41.9 nM and 8.9 nM, respectively. It is expected that this Rapid-TAC platform can be easily extended to many other targets, thus lowering the barrier to access this novel modelity for small molecule drug discovery and faciliate structure activity relationship studies.

摘要

蛋白水解靶向嵌合体(PROTAC)是靶向蛋白降解最常用的技术之一。PROTAC 由靶蛋白配体、E3 连接酶配体和它们之间的连接子组成。传统的 PROTAC 开发方法涉及逐步合成,耗时较长。在此,我们报告了一种通过靶向蛋白配体上邻苯二醛(OPA)基序与市售部分 PROTAC 文库中的胺功能基团之间的无痕偶联反应快速合成 PROTAC(Rapid-TAC)的平台,该文库由不同的 E3 连接酶配体和各种类型和长度的连接子组成。在我们优化的微型化条件下,可以高通量地合成完整的 PROTAC,并且可以直接用于筛选,无需任何进一步的操作,包括纯化。我们通过快速鉴定雄激素受体(AR)和 BRD4 的有效降解剂,证明了该平台的实用性,其 DC 值分别为 41.9 nM 和 8.9 nM。预计该 Rapid-TAC 平台可以很容易地扩展到许多其他靶标,从而降低小分子药物发现和促进构效关系研究这一新型模式的准入门槛。

相似文献

引用本文的文献

2
Methods to accelerate PROTAC drug discovery.加速PROTAC药物发现的方法。
Biochem J. 2025 Jun 25;482(13):BCJ20243018. doi: 10.1042/BCJ20243018.

本文引用的文献

3
Targeted protein degradation: A promise for undruggable proteins.靶向蛋白降解:不可成药蛋白的新希望。
Cell Chem Biol. 2021 Jul 15;28(7):934-951. doi: 10.1016/j.chembiol.2021.04.011. Epub 2021 May 17.
4
Targeted protein degraders crowd into the clinic.靶向蛋白降解剂纷纷涌入临床。
Nat Rev Drug Discov. 2021 Apr;20(4):247-250. doi: 10.1038/d41573-021-00052-4.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验